Linda Coleman

An Indian brand blending ancient Ayurveda with modern science targets the booming U.S. menopause market, expanding its reach into local health stores.

The merger meant to launch a new-economy bank now includes a massive iron mine, raising questions about strategy, valuation, and management expertise.

Backed by its main shareholder, Voltalia gets a €100M loan to accelerate a major transformation plan, aiming for profitability and debt reduction.

Firearms giants clash as Ruger's board blocks a premium offer from its largest shareholder, Beretta, setting the stage for a bitter proxy fight.

A new, imageable liver cancer therapy is one step closer to patients, thanks to a strategic partnership securing a vital US-based medical isotope supply.

Aflac Re Bermuda's first external reinsurance transaction with Japan Post Insurance signals a major strategic shift in Japan's competitive insurance market.

With founding member Crystal Heter as CEO and a Blackstone exec as Chair, Tallgrass signals a new era focused on disciplined growth and energy transition.

Sound Transit's new Crosslake Connection is a world-first engineering marvel, reshaping travel, tourism, and daily life across the Puget Sound region.

Dubai's AIR, owner of Al Fakher, is going public via a SPAC merger. Can it navigate a tricky market and health debates to find growth on Wall Street?

With a $700M war chest and a new veteran president, MISSION Underwriters aims to disrupt Latin America's facultative reinsurance market with its tech platform.

An award-winning franchisee's success story is driving Lee's Famous Recipe Chicken's plan to open six new locations across the competitive Palmetto State.

As elephant Tina faces a life-threatening illness, Samuel L. Jackson pressures the Tulsa Zoo for her and Billy's release to a sanctuary.

As co-founder Jürgen Bickel steps down, 14-year veteran David Männer takes the helm to navigate Storz & Bickel's future and drive Canopy's U.S. plans.

The digital infrastructure firm secured new funding for expansion, but a steep discount in its offering has rattled investors and sent its share price plunging.

Sara Blakely's SNEEX unveils The Ballerina, a new $495 Hy-Heel blending sneaker tech with luxury design. Is this the end of painful high heels?

A new survey reveals inflation and a desire for connection are pushing retirees back into the workforce, not for full-time jobs, but for flexible roles.

With CE Mark approval, Countable Labs brings single-molecule counting PCR to Europe, promising unprecedented precision for gene therapy and diagnostics.

CoreSite's new Google Gold VPP status promises lower latency and simpler access to Google Cloud, raising the bar in a competitive data center market.

Attending a science workshop and a power conference, the OTC-listed firm signals its push to bridge the gap between lab theory and grid reality.

A US-Japan biotech firm secures major funding to advance a first-in-class drug, offering new hope for millions with inherited blood disorders.